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Purpose: Drug overdose and poisoning are common clinical problems and could occur with 
the fluoroquinolones – a new series of synthetic antimicrobial agents. It therefore becomes 
important to study the adsorption of the fluoroquinolones on pharmaceutical adsorbents which 
could serve as possible antidotes for the emergency treatment of fluoroquinolone overdose or 
poisoning when they occur. 
Method: The rate and extent of adsorption of the fluoroquinolones on some pharmaceutical 
adsorbents, namely activated charcoal, kaolin and bentonite were investigated 
spectrophotometrically 
Results: The fluoroquinolones adsorbed on activated charcoal rapidly and attained 
equilibrium within fifteen minutes. The fluoroquinolones however adsorbed on kaolin and 
bentonite less rapidly and attained equilibrium within two hours. Activated charcoal and 
bentonite had high adsorption capacities for the fluoroquinolones while kaolin had low 
adsorption capacities for them. 
Conclusion: Because of the rapid rate of adsorption and high binding capacities exhibited by 
activated charcoal for the fluoroquinolones, it could be an effective antidote for the 
fluoroquinolones in cases of overdose or poisoning.  Activated charcoal has shown a superior 
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INTRODUCTION 
Drug poisoning has been defined as a condition 
produced by any substance which when 
swallowed, inhaled, injected or absorbed 
percutaneously is capable of causing death, 
injury, toxic or untoward reactions1.  Poisoning is 
a very common clinical problem and could occur 
with the fluoroquinolones.  The major principles 
applied in the emergency treatment of accidental 
poisoning by drugs are dilution, emesis and 
adsorption2.  In cases where no specific 
antidotes exist, prevention of further absorption 
of a drug from the oral route is by use of oral 
adsorbents.  This could be of immense benefit in 
the management of drug over dose and/or 
poisoning.  The use of standard adsorbents such 
as activated charcoal in the prevention of further 
absorption of drugs, is recognised in clinical 
practice3.  The safety of activated charcoal is 
remarkable because it is non reactive and non 
absorbable from the gastro-intestinal tract4. 
 
The fluoroquinolones are a new series of 
synthetic antimicrobial agents that have a broad 
spectrum of activity against both gram-positive 
and gram-negative organisms5,6.  They are 
available and active as oral dosage forms.  They 
are well absorbed from the oral route and 
distribute well into body fluids and tissues to 
attain effective inhibitory concentrations7–9.  
Though they are well tolerated, a few adverse 
effects which include gastrointestinal effects, 
disturbances of the CNS, phototoxic reactions, 
liver enzyme abnormalities, arthropathy, 
tendinitis and tendon rupture and prolongation of 
QTc interval have been reported10–13.  Though no 
reports are available on accidental or deliberate 
poisoning with the fluoroquinolones, their 
extensive use warrants investigation into 
possible effective antidotes in cases of 
accidental poisoning or overdose especially in 
elderly patients, in patients with renal 
impairment, and in children in whom these 
fluoroquinolones are contra-indicated as a result 
of drug-induced arthropathy. We present in this 
report our investigations into the in-vitro 
adsorption of the fluoroquinolones exemplified 
by ciprofloxacin, ofloxacin and norfloxacin (the 
most commonly prescribed and available 
fluoroquinolones) on some commercially 
available pharmaceutical adsorbents – activated 
charcoal, kaolin and bentonite.  The aim is to 
provide baseline data that would characterise 
the rate and extent of adsorption of the 
fluoroquinolones on these adsorbents which 
could guide the pharmacist and other healthcare 
givers in the choice of antidotes in the event of 




Ofloxacin powder was kindly supplied by 
Hoechst Germany, through Nigeria – German 
Chemicals, Nigeria.  Pure powders of 
ciprofloxacin hydrochloride and norfloxacin were 
supplied by Sam Pharmaceuticals, Nigeria.  
Adsorbents used included activated charcoal 
and light kaolin from BDH Chemicals, UK, while 
bentonite was from Halewood Chemicals Ltd, 
UK. Hydrochloric acid was from Sigma – Aldrich 
Laboratory, Germany. 
Equipment: Ultrospec 3000 ultra-violet/visible 
spectrophotometer from Pharmacia Biotech, UK 
was used to take all the absorbance readings.  
Thermo- statted shaker bath from Gallenkamp, 
UK set at 37± 0.2°C was used to shake 
fluoroquinolone – adsorbent mixtures and B α T 
hot air oven from Bird and Tat lock UK was used 
to dry the adsorbents. 
Methods 
Standard solutions of each of the 
fluoroquinolones were made in 0.1M 
hydrochloric acid.  The absorbances of each of 
the fluoroquinolone solutions were measured at 
their respective wavelengths of maximum 
absorption and their respective Beer’s plots 
made. 
 
The adsorbents were activated by drying at 
110°C for five hours in the oven for activated 
charcoal and for three hours for kaolin and 
bentonite.  They were then cooled and stored in 
the descicator.  Two types of experiments were 
carried out. The first was to investigate the time 
to attain equilibrium while the second was to find 
out the extent of adsorption of each of the 
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fluoroquinolones on the adsorbents.  For the 
time to reach equilibrium study, 15ml of standard 
solutions of each fluoroquinolone in 0.1M 
hydrochloric acid were added separately into 
25ml volumetric flasks to which graded amounts 
of each adsorbent were put.  Similarly, 15ml of 
0.1M hydrochloric acid was added to  equal 
graded amounts of adsorbent in 25ml volumetric 
flasks.  The slurries were mixed and put in the 
shaker bath set at 80 oscillations per minute and 
at 37 ± 0.2°C.  Aliquots of the mixtures were 
withdrawn at separate time intervals and 
centrifuged at 3000g for five minutes.  Portions 
of the clear supernatant was diluted serially and 
the absorbance of the final solution measured at 
the λmax for the respective drug.  The slurries 
with 15ml 0.1M hydrochloric acid (without 
fluoroquinolone) treated in a similar way served 
as blanks for the absorbance measurements.  
From the Beer’s plot for the fluoroquinolone 
previously made, the amount of free drug in 
solution was determined.  From the results, the 
time to attain equilibrium for each adsorbent was 
determined.  The procedure was repeated for 
each pair of fluoroquinolone and adsorbent. 
For the adsorption equilibrium studies, 
15ml of standard solution of fluoroquinolone was 
added to graded amounts of adsorbent in 
separate 25ml volumetric flasks.  Similarly, 15ml 
of 0.1M hydrochloric acid was added to equal 
graded amounts of adsorbent in 25ml volumetric 
flasks.  The slurries were mixed and put in a 
shaker bath set at 80 oscillations per minute and 
at 37 ± 0.2°C.  The shaking was continued for a 
period exceeding the time to attain equilibrium 
for the adsorbent.  Thereafter, part of the mixture 
was taken and treated as above.  Aliquot of the 
clean supernatant was diluted serially and the 
absorbance of the resultant fluoroquinolone 
solution measured at its λmax.  The slurries with 
15ml 0.1M hydrochloric acid (without 
fluoroquinolone) treated in a similar way served 
as blanks for the absorbance measurements.  
From the Beer’s plot of the fluoroquinolone 
obtained earlier at the λmax, the amounts of free 
drug remaining in solution at equilibrium in the 
presence of graded amounts of the adsorbent 
were determined hence the amount adsorbed 
was calculated.  The procedure was repeated for 
each fluoroquinolone – adsorbent pair. 
RESULTS 
In 0.1M hydrochloric acid, ciprofloxacin, 
ofloxacin and norfloxacin had λmax values of 
277nm, 278nm and 274nm respectively.  At 
each λmax, Beer’s law was obeyed for each 
fluoroquinolone.  The study to know when 
equilibrium was attained showed that with 
activated charcoal as adsorbent, adsorption 
equilibrium was attained rapidly within 15 
minutes with each of the fluoroquinolones.  But 
with kaolin and bentonite, adsorption equilibrium 
was attained less rapidly but within two hours 
with each of the fluoroquinolones.  In the 
presence of graded amounts of each adsorbent, 
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Figure 1 shows a typical Langmuir isotherm plot 
obtained from the adsorption studies.  The 
results of the binding constants obtained for the 
different fluoroquinolones with the different 
adsorbents are shown in Table 1. 
 
DISCUSSION 
0.1M hydrochloric acid was used to mimic the 
acidity of the stomach where drugs that are 
taken orally are retained for some time prior to 
absorption from the gastro-intestinal tract.  
Shaking at 37°C was to mimic gastro-intestinal 
motility and body temperature.  From the time to 
attain equilibrium studies, activated charcoal 
adsorbed the fluoroquinolones rapidly thus 
equilibrium was attained within 15 minutes.  This 
is a desirable feature of an adsorbent antidote.  
The ability to adsorb any poison or excess drug 
rapidly in the case of overdose helps to prevent 
the poison or drug from being absorbed 
significantly and thus reduces fatality and 
mortality.  Activated charcoal has been known to 
have this desirable property, hence it has been 
used generally as an antidote15–17.  On the other 
hand, kaolin and bentonite were slower to attain 
equilibrium with the fluoroquinolones.  It took 
Trop J Pharm Res, June 2006; 5 (1) 535





























Table 1: Values of Langmuir adsorption constants for the fluoroquinolones on pharmaceutical 
adsorbents 






































a Expressed as milligram of drug per gram of adsorbent. 
b AC is activated charcoal bout two hours to attain equilibrium.  This is a 
ong time within which much of the drugs would 
ave been absorbed to cause toxic effects in the 
ase of overdose or poisoning because the 
luoroquinolones are rapidly absorbed from the 
ral route18. 
he binding constants on the adsorbents were 
alculated from the Langmuir isotherms.  The 
esults showed that the fluoroquinolones had a 
trong binding to activated charcoal.  The values 
btained here for the binding constants(k2) of the 
luoroquinolones on activated charcoal are in the 
ame range of values as the those obtained for 
ome other drugs by other workers.  Sellers et 
14 obtained the binding constant of aspirin, 
luthetimide, amitriptyline, chlordiazepoxide, 
iazepam, methaqualone on activated charcoal 
t 37°C and in similar acidic condition as 262, 
52, 133, 157, 136 and 179 respectively.  Thus, 
ctivated charcoal can bind the fluoroquinolones 
uickly and strongly and prevent them from 
eing absorbed from the acidic medium of the 
tomach.  The recommended practice to prevent 
omiting induced by large amounts of activated 
harcoal is to administer 1g of charcoal per 
ilogram of body weight.  If this recommendation 
s followed, very little of any of the 
fluoroquinolones would be available for 
absorption following activated charcoal 
administration.  The binding constants of 
bentonite for the fluoroquinolones were also high 
and of the same order of magnitude as those of 
activated charcoal.  Thus, it can be an effective 
antidote for fluoroquinolone overdose.  Bentonite 
has been shown to have a stronger adsorption 
capacity for aromatic hydrocarbons than kaolin19.  
Though both bentonite and activated charcoal 
had similar binding constants, the rate of 
adsorption on bentonite was slower and thus 
activated charcoal would be preferred to 
bentonite.  For all the fluoroquinolones, the 
binding constants for kaolin was very low.  Thus, 
kaolin cannot effectively bind the 
fluoroquinolones and prevent them from being 
absorbed from the gastro-intestinal tract in the 
case of overdose or accidental poisoning.  
Kaolin cannot be an effective antidote for the 
fluoroquinolones. 
 
The mechanism of adsorption of various drugs 
on activated charcoal has been extensively 
studied and known to proceed by surface 
phenomenon20.  The high binding capacity of 
activated charcoal has been attributed to its high 
surface area.  Similarly, kaolin is an adsorbent 
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Fig. 1: Adsorption of Norfloxacin (A), Ofloxacin (B), and Ciprofloxacin (C) on  Activated Charcoal 
 
that is normally administered in the symptomatic 
treatment of enteritis, colitis and dysentery 
associated with food and alkaloidal poisoning.  
Adsorption of drugs on it is also purely a surface 
phenomenon.  But for bentonite which swells in 
aqueous medium to form a gel, the mechanism 
of adsorption may be by entrapment of the 
fluoroquinolones by the gel rather than by 
surface adsorption.  In the acidic medium used 
in this study, the fluoroquinolones existed in their 
cationic forms.  Thus when adsorbed on the 
surface of the adsorbents they would repel each 
other and incoming cations electrostatically, 
hence they cannot pack densely onto the 
surface.  This may be the reason why 
Langmuir’s isotherm was followed as multi-layer 
adsorption of drugs may not be possible.  
Despite such limitations, activated charcoal still 
adsorbed the fluoroquinolones strongly and 
rapidly. 
 
Kaolin and bentonite were chosen for this study 
because of their reported adsorptive properties 
with other drugs.  They are also commonly used 
as drugs and in pharmaceutical formulations.  
They are safe.  But more importantly, they were 
investigated as alternatives to activated charcoal 
which precipitates vomiting when large doses 
are given.  From the results, it has become 
obvious that the adsorptive capacity and rate of 
adsorption of the fluoroquinolones onto activated 
charcoal were superior to kaolin.  Also, the rate 
of adsorption onto activated charcoal made it a 
better antidote for the fluoroquinolones than 
bentonite.  Moreover, the swelling observed with 
aqueous bentonite solutions will lead to serious 
constipation unless it is co-administered with a 
carthartic.  Magnesium trisilicate – a known 
adsorbent was not investigated in this study 
because magnesium complexes with the 
fluoroquinolones and the effect due to this 
complexation will further complicate its 
adsorptive properties. 
CONCLUSION 
Activated charcoal strongly and rapidly adsorbed 
the fluoroquinolones in acid medium in-vitro.  
Thus, it could be effectively used to prevent 
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fluoroquinolone absorption from the gastro-
intestinal tract in cases of overdose or poisoning.  
Activated charcoal was superior to both kaolin 
and bentonite as an adsorbent for the 
fluoroquinolones.  Though bentonite had a high 
adsorbing capacity for the fluoroquinolones, it 
was slow in adsorbing them.  Moreover, its 
swelling behaviour in aqueous medium makes it 
less attractive.  Kaolin adsorbed the 
fluoroquinolones poorly in acid medium.  
Activated charcoal can serve as a good antidote 
for fluoroquinolone overdose or poisoning.  It 
should not therefore be administered 
concurrently with the fluoroquinolones in the 
treatment of infection as this would lead to 
therapeutic failure.  On the other hand, kaolin 
can be concomitantly administered with the 
fluoroquinolones without adversely affecting the 
therapeutic efficacy of the fluoroquinolones. 
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